Genialis
Artificial Intelligence · Health Care
$13.7Mtotal raised · 3 rounds on record
$11.4Mlatest round · Venture round · Jan 2023 · 3 yr ago
1backers · Redalpine
20stories in the press
Overview
Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.
Funding and backers
Total raised
$13.7M
3 rounds on record
Latest round
$11.4M
Venture round · Jan 2023 · 3 yr ago
Backers
1
Redalpine
The money's age
Long since its last round
45 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 23
Partnership Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models · genialis.com
Jun 22
Launched Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology Drugs · genialis.com
Dec 17, 2025
Took on debt financing $700k · SEC Form D
Jan 19, 2023
Raised a round Venture round $11.4M · SEC Form D
Nov 12, 2017
Raised a round Seed $2.3M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Dec 2025 | $700k | — | SEC Form D |
| Venture round | Jan 2023 | $11.4M | — | SEC Form D |
| Seed | Nov 2017 | $2.3M | — | newswire.com |
Registers and programsofficial lists and records that name the company
| Legal entity | Genialis, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Luka AusecExecutive OfficerSEC Form D
Rafael RosengartenExecutive Officer, DirectorSEC Form D
Miha StajdoharExecutive Officer, DirectorSEC Form D
Tjasa KutinExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Redalpine Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Medicus (MedicusAI) develops AI-powered digital pathology and precision oncology solutions for hospitals, labs, and pharma partners.
Precision oncology, built for Latin America. Point-of-care software and a multimodal cancer atlas.
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics.
Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve…
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Genialis, Inc., Boston, MA
Other sponsors in the same field
Biostate 2026 
Transcarent 
PROS 
Simulations Plus
Alert me
US Department of Labor · latest filing Nov 25, 2024 · Visa details by country
People
Luka Ausec
Executive Officer
Rafael Rosengarten
Executive Officer, Director
Miha Stajdohar
Executive Officer, Director
Tjasa Kutin
Executive Officer
Nadine Geiser
Director
Elia Stupka
Director
Ita Lu
Director
Hamzeh Abdul-Hadi
Director
Drew Volpe
Director
Cedric Odje
Director
Krista McKerracher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
The collaboration pairs the Genialis Supermodel with Inventia Life Science's RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology of specific patient groups Houston & Sydney - September 23, 2026, BusinessWi
Read more
Report
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
HOUSTON & SYDNEY, September 23, 2026--The Genialis Supermodel and Inventia
Read more
Report
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
Read more
Report
The Kodak moment for drug discovery: AI, adaptation, and what stays human TPM podcast #61
Genialis SupermodelGenialis BioBridgeGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next i
Read more
Report
What would you (and your AI) do with the world's largest curated chemistry data catalog? TPM podcast #60
Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology DrugsGenialis BioBridgeGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and healt
Read more
Report
Genialis Supermodel White Paper
A technical guide to the Genialis SupermodelThe Genialis Supermodel is a foundation model of cancer biology that transforms RNA sequencing data into interpretable biomodule scores for biomarker discovery and therapeutic intelligence. This white paper prov
Read more
Report
From motifs to medicines: Harnessing nature's pharmacopeia for novel CNS therapies TPM podcast #59
Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology DrugsGenialis BioBridgeGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and healt
Read more
Report
Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology Drugs
Supermodel-powered platform translates tumor biology across patient populations, addressing a structural gap in East-to-West asset licensing San Diego - June 22, 2026, BusinessWire Genialis, the therapeutic intelligence company, today announced Genialis B
Read more
Report
Fostering innovation at scale: it's all about the ecosystem TPM podcast #58
Genialis ASCO 2026 posterGenialis AACR 2026 posterGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueli
Read more
Report
To Infinity and beyond: the future of comprehensive testing and genetic medicine TPM podcast #57
Genialis ASCO 2026 posterGenialis AACR 2026 posterGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueli
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
68 Harrison Ave #605, PMB 29417, Boston, MA, 02111, US